Chinese Pharmaceutical Market Commercial & Strategic developments to 2024

1
The Chinese Pharmaceutical Market to 2024 -
Commercial Strategic developments in the
Chinese Pharmaceutical Market to 2024
Published Date 01 June, 2016 No of Pages
123 Single User Price 4740
Chinese Pharmaceutical Market Future Forecast
Trends 2024
Click Here To Check Complete Report
2

• The Chinese Pharmaceutical Market to 2024
• Commercial Strategic developments in the
  Chinese Pharmaceutical Market to 2024
• Released 19/3/2014
• 160 Pages
• 140 Tables, Charts and Graphs
• Capture or increase your foothold in the Chinese
  market TODAY
• Establish partnerships to manufacture, distribute
  or develop Chinese products
• Establish anti-counterfeiting systems today to
  increase market size and revenue
• From 2008 to 2013, Chinas OTC drugs market
  reported an average growth of 15 with the market
  reaching 20.6bn in 2013 up from to 11bn in 2008
  - but what will it be this year? Next year? and
  in 5 years time? 
• The OTC drugs market in China was characterized
  by a late start, but fast growth, along with huge
  potential in comparison to that of the mature OTC
  markets in many western countries. Your company
  should be benefiting from this market access
  and this is only the OTC market what has the
  growth been throughout the whole Chinese pharma
  sector? This report will tell you.

3

• Chinas pharmaceutical sales growth is based on
  economic growth in the country This has resulted
  in increased healthcare expenditure internally,
  and increased manufacture and export.
• Increasing urbanisation, disposable income, aging
  population, health education, lifestyle diseases
  and government investments and initiatives for
  healthcare infrastructure improvement have helped
  the market growth considerably.
• Have you captured enough of the Chinese market?
• Annually, an average of 190 is spent for the
  treatment of diabetes, per patient, in China. By
  2030, in China, diabetes is expected to cost Yuan
  173.4bn (28 bn) a year.
• China is expected to top the worlds diabetes
  tables both in terms of sheer numbers and
  population prevalence.
• This is true across a range of complaints and
  products types your company must capture a
  segment of this market TODAY.
• Anti-Counterfeiting and anti-corruption How the
  Chinese market is changing
• Counterfeit drugs are successfully introduced in
  to the lengthy and complicated delivery chain
  because of the highly fragmented nature of the
  market.

4

• A lack of regular inspections by any recognised
  drug enforcement / regulatory bodies, again due
  to the highly fragmented nature of production,
  allows counterfeit / poor quality drugs into the
  Chinese pharma market.
• Moreover, wide spread corruption also helps the
  distribution of counterfeit drugs.
• What are the Chinese regulators, and the global
  manufacturers doing to change this? Find out in
  this unique report.
• Increased inward investment from multiple Big
  Pharma companies has driven investment in RD
  centres as well as opportunities for Chinese
  graduates.
• Many graduates are staying in China those that
  have left now have jobs to return to. Are you
  producing enough of your products in China?
  Increase your profitability through this channel.
• Domestically, increased levels of health
  insurance, increased health education, rising
  numbers of hospitals and increased per capita
  income have all driven the Chinese pharmaceutical
  market.

Make an Inquiry Before Buying
5

• Increase in healthcare expenditure per capita,
  from 157in 2008 to 278 in 2011
• Increasing income and population. The middle
  class population reached 400m in 2010 and is
  expected to reach 500m by 2015
• In 2012, the central government alone invested
  CNY 24.3bn (3.9bn) to improve health service
  infrastructure.
• Key life style changes, which have accelerated
  the diseases such as obesity, diabetes,
  cardiovascular, chronic respiratory diseases
• The over 65 population has increased to 9.1 of
  the total population in China in 2011 from 8.3
  in 2008
• This report also breaks down the market in terms
  of current drugs and products that occupy the
  Chinese market at present examining the key
  prescription and OTC drugs that drive the Chinese
  market.
• In addition to this crucial information this
  report offers analysis and opinion on current RD
  in the country alongside in depth analysis of the
  evolving, global inward investment.

Download Sample Brochure
6

• Discover exactly what the industry leaders are
  doing TODAY -
• Industry information sourced exclusively for this
  report. This information is not available
  anywhere else
• Utilising primary and secondary research sources,
  GMR Data have interviewed leading specialists
  within big pharma, RD, wholesalers,
  distributors, marketeers and key organisations
  specialising in access to the Chinese market, as
  well as Chinese pharmaceutical companies
  accessing the global market.
• From these interviews we have selected original,
  exclusive, transcribed interviews with leading
  specialists in their field This information is
  not available anywhere else.
• This report is the single tool to equip you with
  the latest trends in all pharma sectors and why
  all stakeholders demand development of the
  Chinese pharmaceutical market.
• This report will arm you with all you and your
  company require to develop, price, launch and
  market a product in China, or compete with a
  Chinese product launched in your market.
• With over 160 pages, and over 140 charts,
  tables, figures and graphs, this dedicated
  specialist report will ensure you remain equipped
  and fully informed, to succeed in this
  competitive market.

7
The Chinese Pharmaceutical Market to 2024 -
Commercial Strategic developments in the
Chinese Pharmaceutical Market to 2024
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
the Chinese Pharmaceutical Market and future
opportunities are provided in the report.
Contact 1-302-261-5343 sales_at_marketintelreports.
com www.marketintelreports.com
Click here to order a copy of Chinese
Pharmaceutical Market Report